Carvedilol phosphate hemihydrate

Carvedilol Phosphate Hemihydrate (CAS 610309-89-2, Form I polymorph) is manufactured directly by Polpharma in pharmaceutical grade to EP standard, with EU and US DMF readiness, tailored particle size distribution, and long-standing in-house commercial manufacturing experience. As with Polpharma's other carvedilol offerings, it is a beta-blocker active ingredient used to treat heart failure, hypertension, and reduced cardiac pumping function after a heart attack; in patent-protected markets such as Poland, the supplier makes it available only for regulatory submission or R&D purposes, with patent clearance the buyer's responsibility. It is sold across North America, Central/South America, Western and Eastern Europe, Australasia, Asia, the Middle East, and Africa.